Tobira Therapeutics, Inc. — Form D
Tobira Therapeutics, Inc. of MANALAPAN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-30. The offering totals $31.2M, of which $14.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-08-30
- Form: D
- Accession: 0001409690-10-000005
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $31.2M
- Amount sold: $14.2M
- Remaining: $17.0M
- Investors: 6
- Date of first sale: 2010-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-147084
Issuer
- Name: Tobira Therapeutics, Inc.
- CIK: 0001409690
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 198 ROUTE 9 NORTH, MANALAPAN, NJ, 07726
- Phone: 732-863-5980
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Carol Brosgart | Director | Los Angeles, CA |
| Laurent Fischer | Director | South San Francisco, CA |
| Brian Halak | Director | South San Francisco, CA |
| Patrick Heron | Director | Philadelphia, PA |
| Michael Kamdar | Director | Manalapan, NJ |
| James Sapirstein | Director | Cincinnati, OH |
| Daniel Turner | Director | London, X0 |
| Eckard Weber | Director | SAN DIEGO, CA |
| Kathleen McGowan | Executive Officer | Manalapan, NJ |
| James Sapirstein | Executive Officer | Cincinnati, OH |
| Brian Halak | Executive Officer | South San Francisco, CA |
Other filings by this issuer (2)
More